nifuroxazide Oral suspension 220 mg / 5 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Morocco
GMP approvals
WHO
Manufacturer #17079
A pharmaceutical manufacturer focused on providing high-quality pharmaceutical products for dermatology, gynecology, urology, neurology and feminine care, combining medical skincare and wellness-oriented formulations. The portfolio includes specialized creams, balms, oral supplements and other targeted products designed to support skin health, intimate health and overall well-being across multiple patient needs.
None